Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Nature Reviews Nephrology

• Publication date

  2025-09-11

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1038/s41581-025-01000-wPMID 40935902
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expanding Access to High KDPI Kidney Transplant for Recipients Aged 60 y and Older: Cost Utility and Survival

  2024cited by this paper
• An overview of the perspectives used in health economic evaluations

  2024cited by this paper
• Rapid cost-effectiveness analysis: hemodialysis versus peritoneal dialysis for patients with acute kidney injury in Rwanda

  2024cited by this paper
• Chronic kidney disease and the global public health agenda: an international consensus

  2024cited by this paper
• Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective?

  2024cited by this paper
• Recommendations on the Use of Structured Expert Elicitation Protocols for Healthcare Decision Making: A Good Practices Report of an ISPOR Task Force.

  2024cited by this paper
• Mortality of Peritoneal Dialysis versus Hemodialysis in Older Adults: An Updated Systematic Review and Meta-Analysis

  2024cited by this paper
• Mortality and mode of dialysis: meta-analysis and systematic review

  2024cited by this paper
• An empirical study looking at the potential impact of increasing cost-effectiveness threshold on reimbursement decisions in Thailand

  2024cited by this paper
• Cost-effectiveness of dialysis and kidney transplantation to treat end-stage renal disease in Ukraine.

  2024cited by this paper
• Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses

  2024cited by this paper
• Evaluating Cost-Effectiveness in Using High-Kidney Donor Profile Index Organs.

  2023cited by this paper
• Automated Peritoneal Dialysis With Remote Patient Monitoring: Clinical Effects and Economic Consequences for Poland.

  2023cited by this paper
• Value of an Integrated Home Dialysis Model in the United Kingdom: A Cost-Effectiveness Analysis.

  2023cited by this paper
• The Use of Economic Evaluation Tools in Essential Health Benefits Package Selection for Universal Health Coverage.

  2023cited by this paper
• Developing Criteria for Health Economic Quality Evaluation (CHEQUE) Tool.

  2023cited by this paper
• Extrapolating Clinical Evidence Within Economic Evaluations

  2023cited by this paper
• Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures.

  2023cited by this paper
• Cost-effectiveness of Kidney Transplantation From Donors at Increased Risk of Blood-borne Virus Infection Transmission

  2023cited by this paper
• Validating the rigour of adaptive methods of economic evaluation

  2023cited by this paper
• The development process of economic evaluation guidelines in low- and middle-income countries: a systematic review

  2022cited by this paper
• Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

  2022cited by this paper
• Impact of peritoneal dialysis modality on patient and PD survival: A systematic review

  2022cited by this paper
• Supporting dialysis policy for end stage renal disease (ESRD) in Indonesia: an updated cost-effectiveness model

  2022cited by this paper
• Economic evaluation of three dialysis methods in patients with end-stage renal disease in China

  2022cited by this paper
• Cost-effectiveness of Interventions to Increase Utilization of Kidneys From Deceased Donors With Primary Brain Malignancy in an Australian Setting

  2022cited by this paper
• Cost-Utility Analysis of Universal Maternal Pertussis Immunisation in Thailand: A Comparison of Two Model Structures

  2022cited by this paper
• An ex-ante cost-utility analysis of the deemed consent legislation compared to expressed consent for kidney transplantations in Nova Scotia

  2022cited by this paper
• Comparing the Net Benefits of Adult Deceased Donor Kidney Transplantation for a Patient on the Preemptive Waiting List vs a Patient Receiving Dialysis

  2022cited by this paper
• Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia

  2022cited by this paper
• Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy

  2022cited by this paper
• Value of Information Analysis in Models to Inform Health Policy.

  2021cited by this paper
• Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE

  2021cited by this paper
• Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice

  2021cited by this paper
• The Magnitude of the Health and Economic Impact of Increased Organ Donation on Patients With End-Stage Renal Disease

  2021cited by this paper
• National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison

  2021cited by this paper
• Peritoneal dialysis–first initiative in India: a cost-effectiveness analysis

  2021cited by this paper
• Facets of trust in simulation studies

  2021cited by this paper
• Controversy Over Using Quality-Adjusted Life-Years In Cost-Effectiveness Analyses: A Systematic Literature Review.

  2021cited by this paper
• Long-Term Survival after Kidney Transplantation.

  2021cited by this paper
• Provision of long-term renal replacement therapy to non-national patients in South Africa.

  2021cited by this paper
• The Clinical and Economic Benefit of CMV Matching in Kidney Transplant: A Decision Analysis

  2021cited by this paper
• Building optimal and sustainable kidney care in low resource settings: The role of healthcare systems

  2021cited by this paper
• Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy

  2021cited by this paper
• Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China

  2021cited by this paper
• Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide.

  2020cited by this paper
• On time horizons in health economic evaluations.

  2020cited by this paper
• Economic evaluation of End Stage Renal Disease treatments in Iran

  2020cited by this paper
• Equity–Efficiency Trade-offs Associated With Alternative Approaches to Deceased Donor Kidney Allocation: A Patient-level Simulation

  2020cited by this paper
• Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis

  2020cited by this paper
• To include or not include: renal dialysis policy in the era of universal health coverage

  2020cited by this paper
• Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy

  2020cited by this paper
• Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai End-Stage Renal Disease Patients.

  2020cited by this paper
• Financial implications of dialysis modalities in the developing world: A Chinese perspective

  2020cited by this paper
• Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.

  2020cited by this paper
• Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.

  2020cited by this paper
• Considerations on equity in management of end-stage kidney disease in low- and middle-income countries.

  2020cited by this paper
• Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.

  2020cited by this paper
• Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis

  2020cited by this paper
• The current and future landscape of dialysis

  2020cited by this paper
• Deceased donor kidney allocation: an economic evaluation of contemporary longevity matching practices

  2020cited by this paper
• Donor Kidney Quality and Transplant Outcome: An Economic Evaluation of Contemporary Practice.

  2020cited by this paper
• Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines

  2020cited by this paper
• Generalised cost-effectiveness analysis of 159 health interventions for the Ethiopian essential health service package

  2020cited by this paper
• Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review

  2019cited by this paper
• Increasing access to integrated ESKD care as part of universal health coverage.

  2019cited by this paper
• A guide to value of information methods for prioritising research in health impact modelling

  2019cited by this paper
• Adjusting for Inflation and Currency Changes Within Health Economic Studies.

  2019cited by this paper
• Cost utility analysis of end stage renal disease treatment in Ministry of Health dialysis centres, Malaysia: Hemodialysis versus continuous ambulatory peritoneal dialysis

  2019cited by this paper
• On discount rates for economic evaluations in global health.

  2019cited by this paper
• Cost of hemodialysis in a public sector tertiary hospital of India

  2018cited by this paper
• Model Structuring for Economic Evaluations of New Health Technologies

  2018cited by this paper
• Cost‐effectiveness of using kidneys from hepatitis C nucleic acid test–positive donors for transplantation in hepatitis C–negative recipients

  2018cited by this paper
• An economic assessment of contemporary kidney transplant practice

  2018cited by this paper
• Cost-Effectiveness Thresholds: the Past, the Present and the Future

  2018cited by this paper
• Discounting in Economic Evaluations

  2018cited by this paper
• Ethical Challenges in the Provision of Dialysis in Resource-Constrained Environments.

  2017cited by this paper
• Disease Control Priorities, Third Edition (Volume 9): Improving Health and Reducing Poverty

  2017cited by this paper
• Comparison of Quality of Life in Patients Undergoing Hemodialysis and Peritoneal Dialysis: a Systematic Review and Meta-Analysis

  2017cited by this paper
• Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review.

  2017cited by this paper
• The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries’ Health Economics Practitioners: A Commentary

  2017cited by this paper
• Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia

  2017cited by this paper
• Cost‐effectiveness of haemodialysis and peritoneal dialysis for patients with end‐stage renal disease in Singapore

  2016cited by this paper
• Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience.

  2016cited by this paper
• Cost–effectiveness thresholds: pros and cons

  2016cited by this paper
• Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial

  2016cited by this paper
• More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model

  2016cited by this paper
• The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.

  2016cited by this paper
• Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States

  2016cited by this paper
• Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands

  2016cited by this paper
• Use of the ‘Accountability for Reasonableness’ Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country

  2016cited by this paper
• Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

  2016cited by this paper
• Outcomes of acute kidney injury in children and adults in sub-Saharan Africa: a systematic review.

  2016cited by this paper
• Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease.

  2015cited by this paper
• Worldwide access to treatment for end-stage kidney disease: a systematic review.

  2015cited by this paper
• High-dose hemodialysis versus conventional in-center hemodialysis: a cost-utility analysis from a UK payer perspective.

  2015cited by this paper
• A learning experience from price negotiations for vaccines.

  2015cited by this paper
• In Denmark kidney transplantation is more cost-effective than dialysis.

  2014cited by this paper
• Cost-effectiveness of kidney transplantation from DCD in Italy.

  2014cited by this paper
• Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis

  2014cited by this paper

• A cost- effectiveness and resource requirement comparison to optimize renal dialysis policies in Brunei Darussalam

  2025cites this paper